• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病与线粒体功能障碍

Nonalcoholic fatty liver disease and mitochondrial dysfunction.

作者信息

Wei Yongzhong, Rector R Scott, Thyfault John P, Ibdah Jamal A

机构信息

Division of Gastroenterology and Hepatology, Harry S. Truman VA Medical Center, Columbia, MO 65212, United States.

出版信息

World J Gastroenterol. 2008 Jan 14;14(2):193-9. doi: 10.3748/wjg.14.193.

DOI:10.3748/wjg.14.193
PMID:18186554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2675113/
Abstract

Nonalcoholic fatty liver disease (NAFLD) includes hepatic steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. NAFLD is the most common liver disorder in the United States and worldwide. Due to the rapid rise of the metabolic syndrome, the prevalence of NAFLD has recently dramatically increased and will continue to increase. NAFLD has also the potential to progress to hepatocellular carcinoma (HCC) or liver failure. NAFLD is strongly linked to caloric overconsumption, physical inactivity, insulin resistance and genetic factors. Although significant progress in understanding the pathogenesis of NAFLD has been achieved in years, the primary metabolic abnormalities leading to lipid accumulation within hepatocytes has remained poorly understood. Mitochondria are critical metabolic organelles serving as "cellular power plants". Accumulating evidence indicate that hepatic mitochondrial dysfunction is crucial to the pathogenesis of NAFLD. This review is focused on the significant role of mitochondria in the development of NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)包括肝脂肪变性、非酒精性脂肪性肝炎(NASH)、纤维化和肝硬化。NAFLD是美国和全球最常见的肝脏疾病。由于代谢综合征的迅速增加,NAFLD的患病率最近急剧上升,并将继续增加。NAFLD也有可能进展为肝细胞癌(HCC)或肝衰竭。NAFLD与热量摄入过多、缺乏运动、胰岛素抵抗和遗传因素密切相关。尽管近年来在理解NAFLD发病机制方面取得了重大进展,但导致肝细胞内脂质积累的主要代谢异常仍知之甚少。线粒体是作为“细胞发电厂”的关键代谢细胞器。越来越多的证据表明,肝脏线粒体功能障碍对NAFLD的发病机制至关重要。本综述重点关注线粒体在NAFLD发展中的重要作用。

相似文献

1
Nonalcoholic fatty liver disease and mitochondrial dysfunction.非酒精性脂肪性肝病与线粒体功能障碍
World J Gastroenterol. 2008 Jan 14;14(2):193-9. doi: 10.3748/wjg.14.193.
2
Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中脂肪变性的分子机制
Nutr Hosp. 2011 May-Jun;26(3):441-50. doi: 10.1590/S0212-16112011000300003.
3
Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.脂肪酸在肥胖和脂肪肝发病机制中的作用:减肥手术的影响
Semin Liver Dis. 2008 Nov;28(4):407-26. doi: 10.1055/s-0028-1091985. Epub 2008 Oct 27.
4
Pathogenesis of nonalcoholic steatohepatitis (NASH).非酒精性脂肪性肝炎(NASH)的发病机制。
Chin J Dig Dis. 2006;7(1):7-11. doi: 10.1111/j.1443-9573.2006.00237.x.
5
Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.非酒精性脂肪性肝病发病机制中的氧化还原平衡:机制和治疗机会。
Antioxid Redox Signal. 2011 Sep 1;15(5):1325-65. doi: 10.1089/ars.2009.3058. Epub 2011 Apr 20.
6
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
7
Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.非酒精性脂肪性肝病/肝炎:流行病学、发病机制、临床表现和治疗。
Dig Dis. 2012;30(2):158-62. doi: 10.1159/000336669. Epub 2012 Jun 20.
8
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
9
Fatty liver: role of inflammation and fatty acid nutrition.脂肪肝:炎症和脂肪酸营养的作用。
Prostaglandins Leukot Essent Fatty Acids. 2010 Apr-Jun;82(4-6):265-71. doi: 10.1016/j.plefa.2010.02.012. Epub 2010 Mar 2.
10
[Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].肥胖儿童非酒精性脂肪性肝病和代谢综合征的患病率
Zhonghua Er Ke Za Zhi. 2009 Feb;47(2):114-8.

引用本文的文献

1
A murine model of gestational diabetes reveals MASLD risk and alterations in markers of hepatic mitochondrial metabolism.一种妊娠期糖尿病的小鼠模型揭示了代谢相关脂肪性肝病(MASLD)的风险以及肝脏线粒体代谢标志物的改变。
Front Endocrinol (Lausanne). 2025 Jun 25;16:1498764. doi: 10.3389/fendo.2025.1498764. eCollection 2025.
2
Ketone metabolites in metabolic dysfunction-associated steatotic liver disease progression: optimizing keto-therapeutic strategies.代谢功能障碍相关脂肪性肝病进展中的酮类代谢产物:优化酮治疗策略
Am J Physiol Endocrinol Metab. 2025 Aug 1;329(2):E290-E301. doi: 10.1152/ajpendo.00178.2025. Epub 2025 Jul 7.
3
PI3K/AKT signaling pathway plays an important role in the pathogenesis of metabolic dysfunction-associated steatotic liver disease.PI3K/AKT信号通路在代谢功能障碍相关脂肪性肝病的发病机制中起重要作用。
Sci Rep. 2025 Jul 1;15(1):20593. doi: 10.1038/s41598-025-07612-3.
4
The Hepatoprotective Properties of Gentiopicroside, Sweroside, and Swertiamarin Against Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).龙胆苦苷、獐牙菜苷和獐牙菜苦苷对代谢功能障碍相关脂肪性肝病(MASLD)的肝脏保护特性。
Biomolecules. 2025 May 16;15(5):726. doi: 10.3390/biom15050726.
5
Endonuclease G promotes hepatic mitochondrial respiration by selectively increasing mitochondrial tRNA production.核酸内切酶G通过选择性增加线粒体tRNA的产生来促进肝脏线粒体呼吸。
Proc Natl Acad Sci U S A. 2025 Jan 7;122(1):e2411298122. doi: 10.1073/pnas.2411298122. Epub 2025 Jan 3.
6
The Effects of Warm Acupuncture on the Expression of in High-Fat Diet-Induced MAFLD Rats.温针疗法对高脂饮食诱导的MAFLD大鼠中[具体物质]表达的影响
Curr Issues Mol Biol. 2024 Oct 17;46(10):11580-11592. doi: 10.3390/cimb46100687.
7
Mitochondrial topoisomerase I (Top1MT) prevents the onset of metabolic dysfunction-associated steatohepatitis (MASH) in mice.线粒体拓扑异构酶I(Top1MT)可预防小鼠代谢功能障碍相关脂肪性肝炎(MASH)的发生。
bioRxiv. 2024 Sep 5:2024.09.05.611454. doi: 10.1101/2024.09.05.611454.
8
Targeting Mitochondrial Dysfunction for the Prevention and Treatment of Metabolic Disease by Bioactive Food Components.通过生物活性食品成分靶向线粒体功能障碍以预防和治疗代谢性疾病
J Lipid Atheroscler. 2024 Sep;13(3):306-327. doi: 10.12997/jla.2024.13.3.306. Epub 2024 Jun 17.
9
identification of bioactive components of for adjusting mitochondria against metabolic dysfunction-associated fatty liver disease.用于调节线粒体以对抗代谢功能障碍相关脂肪性肝病的生物活性成分的鉴定。
Heliyon. 2024 Aug 3;10(16):e35645. doi: 10.1016/j.heliyon.2024.e35645. eCollection 2024 Aug 30.
10
miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression.肝细胞中 miR-33 的缺失可减轻 MASLD-MASH-HCC 的进展。
JCI Insight. 2024 Aug 27;9(19):e168476. doi: 10.1172/jci.insight.168476.

本文引用的文献

1
TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents.肿瘤坏死因子-α下调肥胖啮齿动物脂肪和肌肉中内皮型一氧化氮合酶的表达及线粒体生物合成。
J Clin Invest. 2006 Oct;116(10):2791-8. doi: 10.1172/JCI28570. Epub 2006 Sep 14.
2
Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice.尿酸和抗TNF抗体可改善ob/ob小鼠的线粒体功能障碍。
Hepatology. 2006 Sep;44(3):581-91. doi: 10.1002/hep.21313.
3
Non-alcoholic steatohepatitis and metabolic syndrome.非酒精性脂肪性肝炎与代谢综合征
Curr Opin Clin Nutr Metab Care. 2006 Sep;9(5):637-42. doi: 10.1097/01.mco.0000241677.40170.17.
4
Invasive and non-invasive investigations for tamoxifen-induced non-alcoholic steatohepatitis (NASH): the benefit of computed tomography scan guided liver biopsy.他莫昔芬诱导的非酒精性脂肪性肝炎(NASH)的侵入性和非侵入性检查:计算机断层扫描引导下肝活检的益处
Pathology. 2006 Jun;38(3):270-1. doi: 10.1080/00313020600699201.
5
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease.PGC-1 共激活因子:健康与疾病中能量代谢的诱导性调节因子
J Clin Invest. 2006 Mar;116(3):615-22. doi: 10.1172/JCI27794.
6
The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase.由于NEIL1 DNA糖基化酶基因敲除导致的代谢综合征。
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1864-9. doi: 10.1073/pnas.0507444103. Epub 2006 Jan 30.
7
Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.非酒精性脂肪性肝炎中的线粒体功能障碍:病因、后果及可能的预防方法。
Mitochondrion. 2006 Feb;6(1):1-28. doi: 10.1016/j.mito.2005.10.004. Epub 2006 Jan 5.
8
Nonalcoholic steatohepatitis and the metabolic syndrome.非酒精性脂肪性肝炎与代谢综合征
Am J Med Sci. 2005 Dec;330(6):326-35. doi: 10.1097/00000441-200512000-00011.
9
Metabolic control through the PGC-1 family of transcription coactivators.通过转录共激活因子PGC-1家族进行代谢控制。
Cell Metab. 2005 Jun;1(6):361-70. doi: 10.1016/j.cmet.2005.05.004.
10
The natural history of nonalcoholic fatty liver disease: a population-based cohort study.非酒精性脂肪性肝病的自然史:一项基于人群的队列研究。
Gastroenterology. 2005 Jul;129(1):113-21. doi: 10.1053/j.gastro.2005.04.014.